Best response to treatment with venetoclax 400 mg + azacitidine. mOR = CR + mCR + PR. HI responders = 51 patients (28 patients with CR, 20 patients with mCR, and 3 patients with HI response only). No PR were reported. PD, progressive disease; SD, stable disease.